Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Goes Global: Trade Talks Suggest Drug Prices Are Part Of Mission

Executive Summary

FDA's involvement in trade negotiations with Australia is the latest sign that the agency's mission is evolving under Commissioner McClellan toward the once-taboo topic of pharmaceutical prices

You may also be interested in...



Drug R&D May Depend On Govt. Funds If Price Disparities Persist – Crawford

Drug price controls in the international market could lead to a reliance on government funds for pharmaceutical R&D, FDA Acting Commissioner Lester Crawford said

Drug R&D May Depend On Govt. Funds If Price Disparities Persist – Crawford

Drug price controls in the international market could lead to a reliance on government funds for pharmaceutical R&D, FDA Acting Commissioner Lester Crawford said

Genentech Rx For Global Pricing: Refuse To Sell Unless Price Is “Reasonable”

Pharmaceutical companies should not market products in countries that do not allow "reasonable" prices for drugs, Genentech CEO Arthur Levinson declared during a March 12 investor conference

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS043204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel